Indication

in children from 6 months to 17 years old, for moderate sedation before a therapeutic or diagnostic procedure or as premedication before anaesthesia.

Medicine details

Medicine name:
midazolam (Ozalin)
SMC ID:
SMC2392
Pharmaceutical company
Primex Pharmaceuticals
Submission type
Abbreviated
Publication due date:
11 October 2021